MENU
ARGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
argenx SE (ARGX) Ownership - Who owns argenx SE?
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
33.38B
P/E Ratio
42.98
Total Cash
3.38B
Projected Growth
N/A
Total Debt
39.05M
Revenue
2.19B
Risk (Beta)
0.21
Dividend Yield
N/A
Total Cash/Share
55.40
Total Debt/Equity
N/A
Revenue/Share
33.60 USD as % of share price
Fundamentals
ARGX
Capitalization
33.4B
P/E Ratio
42.98
Risk (Beta)
0.21
Dividend Yield
N/A
Total Cash
3.38B
Total Cash/Share
55.40
Total Debt
39.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
33.60%
Revenue
2.19B
ROE
N/A
Book Value
5.5B
P/B Ratio
6.09
Cash Flow
N/A
Earnings
13.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.23M
Current Ratio
7.29
Current Revenue Per Employee
450525.30
Dividends Per Share - Security
N/A
EBITDA
105M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.16
Revenue To Assets
15.51
Shares Held By Institutions
46B
Shares Outstanding - Current
61M
Total Liabilities
704M
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.743
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of antibody-based medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com